YOLFTbeta
00

Dong Sung Bio Pharm.Co.,Ltd.

002210 · KO · Healthcare / Drug Manufacturers - Specialty & Generic

1,075.00KRW-26.00 (-2.36%)

Price History

Full chart

Market Stats

Previous Close1,101.00
Open1,106.00
Day Range1,075.00 – 1,107.00
52-Week Range1,239.00 – 2,525.00
Volume43.72K
Market Cap123.09B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield0.00%
Beta-0.40
50-Day Avg1,415.60
200-Day Avg1,083.74

About

Dong Sung Bio Pharm.Co.,Ltd. manufactures and sells pharmaceuticals and cosmetics in South Korea. The company offers over the counter drugs, such as emollient, vitamin supplement, alopecia treatment, antihistamines, liver disease treatment, fire extinguisher solvent, antiviral, eye drops, menopause treatment, sleep inducer, antipyretic, analgesic, anti-inflammatory, vascular reinforcement, broad-spectrum skin disease treatment, gum disease treatment, blood circulation improver, scar treatment, dry stomach, eye nourishment, abdominal obesity treatment, anti-soil agent, respiratory solvent, and antifungal agent. It also provides prescription drugs, including endocrine system, corticosteroids, fire extinguishing system, circulatory system, psychotropic solvents, tumor therapy, analgesic anti-inflammatory, cutaneous urinary system, antiviral, antibiotics, and respiratory system. In addition, the company offers hair dye, cosmetics, health functional supplements, nasal spray, household goods, muscle taping, disinfectant, toothpaste, anti-hair loss shampoo, and sanitary napkin. The company was founded in 1957 and is headquartered in Seoul, South Korea.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Won-gyun Na
  • Employees298
  • HeadquartersDongsung Building, Seoul, South Korea, 01340, Korea
  • Websitehttps://dongsung-pharm.com

Leadership

  • Mr. Won-gyun NaChairman & CEO · b. 1986
  • Ms. Young-ja OhManaging Director · b. 1961
  • Mr. Cheol-woo KimManaging Director · b. 1965
  • Mr. Sang-hyeon ParkManaging Director · b. 1967

Financials

Income Statement

Currency: KRW2008-12-312009-12-312010-12-312011-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue62.23B68.72B71.93B78.44B79.72B82.39B91.91B86.54B87.80B84.41B93.33B88.59B88.45B87.17B
Growth (%)-+10.43%+4.66%+9.06%+1.63%+3.34%+11.56%-5.85%+1.46%-3.86%+10.57%-5.07%-0.16%-1.45%
Cost of Revenue25.51B27.72B32.04B33.23B42.62B46.28B56.72B53.46B53.65B50.86B51.27B47.16B49.69B50.06B
Gross Profit36.72B41.00B39.88B45.21B37.10B36.10B35.19B33.08B34.15B33.54B42.06B41.44B38.76B37.11B
Gross Margin59.01%59.66%55.45%57.64%46.53%43.82%38.29%38.22%38.89%39.74%45.06%46.77%43.82%42.57%
Operating Expense35.24B39.90B42.99B42.11B39.39B35.15B37.00B40.61B37.82B38.84B45.15B40.77B44.49B47.23B
Operating Income1.49B1.10B-3.11B3.10B-2.29B955.13M-1.81B-7.53B-3.67B-5.30B-3.10B665.08M-5.73B-10.12B
Operating Margin2.39%1.61%-4.32%3.96%-2.87%1.16%-1.97%-8.70%-4.18%-6.28%-3.32%0.75%-6.48%-11.61%
EBITDA-----2.71B-3.02B-5.25B-7.86B-1.44B1.58B-415.87M-9.20B-16.76B
EBITDA Margin-----3.29%-3.28%-6.07%-8.95%-1.71%1.69%-0.47%-10.40%-19.23%
Net Income3.66B568.43M-7.85B1.70B-1.66B-198.26M-5.74B-8.39B-14.08B-4.31B-2.12B-5.97B-14.57B-25.74B
Net Income Margin5.88%0.83%-10.92%2.17%-2.08%-0.24%-6.25%-9.69%-16.04%-5.11%-2.27%-6.73%-16.47%-29.53%
R&D252.34M332.14M193.10M377.33M2.35B2.46B3.00B3.10B3.37B3.40B4.12B4.17B4.52B3.73B
R&D as % of Total Revenue0.41%0.48%0.27%0.48%2.95%2.99%3.27%3.59%3.84%4.02%4.41%4.71%5.11%4.27%
Interest Expense0000001.69B1.40B850.30M712.20M1.31B2.24B3.74B9.75B
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%1.84%1.62%0.97%0.84%1.40%2.53%4.23%11.18%

Balance Sheet

Currency: KRW2008-12-312009-12-312010-12-312011-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets124.57B127.91B127.81B124.58B125.39B124.18B140.20B131.73B125.72B104.58B107.70B111.00B140.67B168.44B
Total Liabilities56.75B59.94B68.71B64.38B69.77B59.91B82.71B61.63B70.77B58.14B64.89B75.09B96.70B145.07B
Total Equity67.82B67.97B59.10B60.20B55.62B64.27B57.48B70.10B54.95B46.44B42.81B35.91B43.97B23.37B
Cash5.24B2.92B7.39B8.15B2.91B4.05B2.21B4.28B14.35B3.14B4.09B6.44B3.15B3.86B
Net Debt-----27.18B40.44B23.37B11.97B26.12B32.84B36.74B48.84B60.22B

Cash Flow

Currency: KRW2008-12-312009-12-312010-12-312011-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-365.26M-5.02B3.68B-2.64B-3.34B1.80B1.39B-8.31B5.01B-2.75B-3.88B-6.29B-14.84B-12.86B
Investing Cash Flow5.24B-1.44B-402.23M3.40B----------
Financing Cash Flow-5.40B4.15B1.19B-145.40M----------
Capital Expenditure417.02M721.58M847.33M380.70M2.84B3.00B2.13B1.42B6.92B2.32B642.90M923.56M2.47B1.34B
Free Cash Flow------1.21B-733.54M-9.73B-1.91B-5.08B-4.53B-7.22B-17.30B-14.20B
Dividends Paid544.74M544.74M544.74M529.74M----------
FCF to OCF------67.02%-52.65%117.12%-38.17%184.45%116.56%114.68%116.62%110.41%

Earnings

Report DateMar 31, 2005Jun 30, 2005Sep 30, 2005Jun 30, 2006Sep 30, 2006Dec 31, 2006Mar 31, 2009Jun 30, 2009Sep 30, 2009Dec 31, 2009Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Sep 30, 2014Dec 31, 2014Mar 31, 2015Jun 30, 2015Sep 30, 2015Dec 31, 2015Mar 31, 2016Aug 12, 2016Nov 11, 2016Mar 2, 2017May 15, 2017Aug 10, 2017Nov 14, 2017Feb 26, 2018May 15, 2018Aug 13, 2018Nov 14, 2018Feb 11, 2019May 15, 2019Aug 14, 2019Nov 14, 2019Mar 18, 2020Mar 31, 2020Jun 30, 2020Sep 30, 2020Dec 31, 2020Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate----------------------------------------------------------------------
EPS Actual0.653.465.242.6916.814.4432.4210.7710.35-22.2353.7522.19-17.3586.2895.0810.6239.68-4.80-21.06-121.6012.297.627.26-593.4850.1613.62-28.88-10.488.15-64.39-34.006.9613.2410.8718.55-47.22-27.02-8.55-566.52280.31-69.80-100.769.59-201.86-216.361.90-107.73-277.76-38.29-4.76-22.17-134.01-62.08-80.8734.28-27.7524.98-35.55-1.95-97.39-7.15-46.36-63.91-519.85-56.14-777.974.65-235.760.56-62.60
Surprise----------------------------------------------------------------------
Timing-----------------------------Pre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hours--------------------------

Key Statistics & Ratios

Market Cap123.09B
Enterprise Value120.25B
Trailing P/E0.00
Forward P/E0.00
PEG Ratio0.00
Price / Sales1.57
Price / Book1.36
Revenue (TTM)78.44B
Gross Profit (TTM)45.21B
EBITDA4.61B
Profit Margin2.17%
Operating Margin-0.67%
Return on Equity2.85%
Return on Assets1.54%
Shares Outstanding96.62M
Shares Float9.84M
Beta-0.40
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20131×
30.00Dec 27, 2013
20121×
30.00Dec 27, 2012
20111×
30.00Dec 28, 2011
20101×
30.00Dec 29, 2010
20091×
30.00Dec 29, 2009
20081×
30.00Dec 29, 2008
20071×
30.00Dec 27, 2007
20061×
40.00Dec 27, 2006
20051×
30.00Dec 28, 2005
20041×
30.00Dec 29, 2004
20031×
30.00Dec 29, 2003
20021×
30.00Dec 27, 2002
20011×
30.00Jan 2, 2001
20001×
30.00Jan 4, 2000
19991×
10.00Jan 4, 1999
19981×
9.71Jan 3, 1998
19971×
85.69Jan 3, 1997
19961×
24.35Jan 3, 1996

Stock Splits

  • Dec 22, 20085:1